Surgery Partners Price to Sales Ratio 2013-2023 | SGRY
Historical PS ratio values for Surgery Partners (SGRY) over the last 10 years. The current P/S ratio for Surgery Partners as of May 03, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Surgery Partners P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-03 | 24.53 | 1.13 | |
| 2023-12-31 | 31.99 | $21.78 | 1.47 |
| 2023-09-30 | 29.25 | $23.61 | 1.24 |
| 2023-06-30 | 44.99 | $25.23 | 1.78 |
| 2023-03-31 | 34.47 | $26.91 | 1.28 |
| 2022-12-31 | 27.86 | $28.20 | 0.99 |
| 2022-09-30 | 23.40 | $28.93 | 0.81 |
| 2022-06-30 | 28.92 | $28.88 | 1.00 |
| 2022-03-31 | 55.05 | $29.80 | 1.85 |
| 2021-12-31 | 53.41 | $32.55 | 1.64 |
| 2021-09-30 | 42.34 | $35.37 | 1.20 |
| 2021-06-30 | 66.62 | $38.59 | 1.73 |
| 2021-03-31 | 44.26 | $38.42 | 1.15 |
| 2020-12-31 | 29.01 | $38.16 | 0.76 |
| 2020-09-30 | 21.90 | $37.63 | 0.58 |
| 2020-06-30 | 11.57 | $36.84 | 0.31 |
| 2020-03-31 | 6.53 | $38.39 | 0.17 |
| 2019-12-31 | 15.66 | $37.97 | 0.41 |
| 2019-09-30 | 7.39 | $37.48 | 0.20 |
| 2019-06-30 | 8.14 | $37.13 | 0.22 |
| 2019-03-31 | 11.28 | $37.00 | 0.30 |
| 2018-12-31 | 9.79 | $36.89 | 0.27 |
| 2018-09-30 | 16.50 | $36.19 | 0.46 |
| 2018-06-30 | 14.90 | $33.53 | 0.44 |
| 2018-03-31 | 17.15 | $30.42 | 0.56 |
| 2017-12-31 | 12.10 | $27.82 | 0.44 |
| 2017-09-30 | 10.35 | $24.64 | 0.42 |
| 2017-06-30 | 22.75 | $24.19 | 0.94 |
| 2017-03-31 | 19.50 | $24.22 | 0.81 |
| 2016-12-31 | 15.85 | $23.82 | 0.67 |
| 2016-09-30 | 20.24 | $24.50 | 0.83 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.118B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.475B | 15.37 |
| Cencora (COR) | United States | $44.674B | 17.41 |
| ICON (ICLR) | Ireland | $25.493B | 24.07 |
| DiDi Global (DIDIY) | China | $24.448B | 0.00 |
| Avantor (AVTR) | United States | $16.791B | 24.72 |
| Viatris (VTRS) | United States | $14.026B | 4.03 |
| CochLear (CHEOY) | Australia | $13.917B | 0.00 |
| Revvity (RVTY) | United States | $12.428B | 21.78 |
| Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
| Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
| Natera (NTRA) | United States | $11.711B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
| Solventum (SOLV) | United States | $11.153B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
| HealthEquity (HQY) | United States | $6.740B | 50.35 |
| Organon (OGN) | United States | $5.043B | 4.78 |
| Bausch + Lomb (BLCO) | Canada | $4.779B | 19.16 |
| Doximity (DOCS) | United States | $4.494B | 33.46 |
| PACS (PACS) | United States | $3.725B | 0.00 |
| Sotera Health (SHC) | United States | $3.119B | 15.31 |
| Progyny (PGNY) | United States | $3.049B | 51.16 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.783B | 29.48 |
| Premier (PINC) | United States | $2.460B | 9.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
| Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.970B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Alignment Healthcare (ALHC) | United States | $1.268B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
| Embecta (EMBC) | United States | $0.584B | 3.86 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.514B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| CareDx (CDNA) | United States | $0.503B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| MultiPlan (MPLN) | United States | $0.422B | 0.00 |
| Beauty Health (SKIN) | United States | $0.415B | 0.00 |
| ModivCare (MODV) | United States | $0.383B | 7.18 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
| Sharecare (SHCR) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.161B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.080B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |